Page last updated: 2024-08-21

indirubin and indirubin-5-sulfonate

indirubin has been researched along with indirubin-5-sulfonate in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Briem, H; Brumby, T; Eisenbrand, G; Jautelat, R; Krüger, M; Lücking, U; Prien, O; Schäfer, M; Schwahn, S; Siemeister, G1
Grundt, P; Jones-Brando, L; Krivogorsky, B; Yolken, R1
Bai, G; Chen, Y; Wang, H; Wang, J; Wang, Z; Wei, C; Xu, Y; Yao, Q; Zhang, L1
Li, J; Liang, C; Liu, C; Qiang, T; Ren, X; Shi, Z; Tian, L; Xing, Y1

Reviews

2 review(s) available for indirubin and indirubin-5-sulfonate

ArticleYear
Anticancer potential of indirubins in medicinal chemistry: Biological activity, structural modification, and structure-activity relationship.
    European journal of medicinal chemistry, 2021, Nov-05, Volume: 223

    Topics: Antineoplastic Agents; Cell Survival; Chemistry, Pharmaceutical; Drugs, Chinese Herbal; Humans; Indoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Oximes; Structure-Activity Relationship

2021
From Structure Modification to Drug Launch: A Systematic Review of the Ongoing Development of Cyclin-Dependent Kinase Inhibitors for Multiple Cancer Therapy.
    Journal of medicinal chemistry, 2022, 05-12, Volume: 65, Issue:9

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Cycle; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinases; Female; Humans; Pharmaceutical Preparations; Protein Kinase Inhibitors

2022

Other Studies

2 other study(ies) available for indirubin and indirubin-5-sulfonate

ArticleYear
From the insoluble dye indirubin towards highly active, soluble CDK2-inhibitors.
    Chembiochem : a European journal of chemical biology, 2005, Volume: 6, Issue:3

    Topics: Adenosine Triphosphate; Binding Sites; Cell Cycle Proteins; Coloring Agents; Cyclin-Dependent Kinase Inhibitor p21; Indoles; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Protein Structure, Tertiary; Solubility; Sulfonamides

2005
Inhibition of Toxoplasma gondii by indirubin and tryptanthrin analogs.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:12

    Topics: Animals; Antiprotozoal Agents; Drugs, Chinese Herbal; Indoles; Isatis; Parasitic Sensitivity Tests; Quinazolines; Toxoplasma

2008